Načítá se...
PIAS1 protects against myocardial ischemia-reperfusion injury by stimulating PPARγ SUMOylation
BACKGROUND: Myocardial ischemia-reperfusion injury (IRI) has become one of the most serious complications after reperfusion therapy in patients with acute myocardial infarction. Small ubiquitin-like modification (SUMOylation) is a reversible process, including SUMO E1-, E2-, and E3-mediated SUMOylat...
Uloženo v:
| Vydáno v: | BMC Cell Biol |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6233564/ https://ncbi.nlm.nih.gov/pubmed/30419807 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12860-018-0176-x |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|